Treatment of juvenile Graves' disease and its ophthalmic complication: The 'European way'

European Journal of Endocrinology

Volumn 150, Issue 4, 2004, Pages 407-414

  Krassas, G E ^a  

^a PANAGIA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CORTICOSTEROID; IODINE 131; OCTREOTIDE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; CHILD; CHILDHOOD DISEASE; CHOLESTASIS; CONGENITAL DISORDER; DECOMPRESSION SURGERY; DISEASE EXACERBATION; DRUG COST; DRUG HALF LIFE; DRUG MECHANISM; DRUG PREFERENCE; DRUG SAFETY; ENDOCRINE OPHTHALMOPATHY; EUROPE; GEOGRAPHIC DISTRIBUTION; GONADAL DISEASE; GRAVES DISEASE; HEPATITIS; HUMAN; HYPOTHYROIDISM; INDIVIDUALIZATION; LIVER TOXICITY; POLYARTHRITIS; PRIORITY JOURNAL; REVIEW; THYROID ADENOMA; THYROID CANCER; THYROTOXICOSIS; TREATMENT FAILURE; UNITED STATES;

ANTITHYROID AGENTS; CHILD; EUROPE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES;

EID: 2342578125     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500407     Document Type: Review

References (97)

1. Marketos SG, Eftychiadis A & Koutras DA. The first recognition of the association between goiter and exophthalmos. Journal of Endocrinological Investigation 1983 6 401-403.
2. Drury MI. Robert Graves - 150 years ago. Irish Medical Science 1985 154 470-471.
3. Parry C. Collections from the Unpublished Medical Writings, vol 2 p 111. London: Underwoods, 1825.
4. Graves RJ. Newly observed affection of the thyroid gland in females. In Classic Descriptions of Disease: With Biographical Sketches of the Authors, p 280. Ed. RH Major. Springfield, IL: Charles Thomas, 1945.
5. Foley TP Jr. Thyrotoxicosis in childhood. Pediatric Annals 1992 21 43-46, 48-49.
6. Lavard L, Ranlov I, Perrild H, Andersen O & Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. European Journal of Endocrinology 1994 130 565-568.
7. Haraldsson A, Gudmundsson ST, Larusson G & Sigurdsson G. Thyrotoxicosis in Iceland 1980-1982. An epidemiological survey. Acta Medica Scandinavica 1985 217 253-258.
8. Sato T, Takata I, Taketani T, Saida K & Nakajima H. Concurrence of Graves' disease and Hashimoto's thyroiditis. Archives of Disease in Childhood 1977 52 951-955.
9. Abe K, Konno M, Sato T & Matsuura N. Hyperfunctioning thyroid nodules in children. American Journal of Diseases of Children 1980 134 961-963.
10. Sussman L, Librik L & Clayton GW. Hyperthyroidism attributable to a hyperfunctioning thyroid carcinoma. Journal of Pediatrics 1968 72 208-213.
11. Fradkin JE & Wolff J. Iodide-induced thyrotoxicosis. Medicine 1983 62 1-20.
12. Weintraub BD, Gershengorn MC, Kourides IA & Fein H. Inappropriate secretion of thyroid-stimulating hormone. Annals of Internal Medicine 1981 95 339-351.
13. Gorman CA, Wahner HW & Tauxe WN. Metabolic malingerers. Patients who deliberately induce or perpetuate a hypermetabolic or hypometabolic state. American Journal of Medicine 1970 48 708-714.
14. Saxena KM, Crawford JD & Talbot NB. Childhood thyrotoxicosis: a long-term perspective. British Medical Journal 1964 2 1153-1158.
15. Friedman JM & Fialkow PJ. The genetics of Graves' disease. Clinics in Endocrinology and Metabolism 1978 7 47-65.
16. Zakarija M, McKenzie JM & Hoffman WH. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1986 62 368-371.
17. Barnes HV & Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves' disease): thirty years' experience in children and adolescents. Journal of Pediatrics 1977 91 313-320.
18. Vaidya VA. Bongiovanni AM, Parks JS, Tenore A & Kirkland RT. Twenty-two years' experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974 54 565-570.
19. Kogut MD, Kaplan SA, Collip PJ, Tiamsic T & Boyle D. Treatment of hyperthyroidism in children. New England Journal of Medicine 1965 272 217-221.
20. Inada M, Nishikawa M, Naito K, Ishii H, Tanaka K, Mashio Y et al. Sex- and age-related changes of exophthalmos in Graves' disease. Endocrinologica Japonica 1981 28 515-519.
21. Gruters A. Ocular manifestations in children and adolescents with thyrotoxicosis. Experimental and Clinical Endocrinology and Diabetes 1999 107 (Suppl 5) S172-S174.
22. Young LA. Dysthyroid ophthalmopathy in children. Journal of Pediatric Ophthalmology and Strabismus 1979 16 105-107.
23. Uretsky SH, Kennerdell JS & Gutai JP. Graves' ophthalmopathy in childhood and adolescence. Archives of Ophthalmology 1980 98 1963-1964.
24. Liu GT, Heher KL, Katowitz JA, Kazim M, Moazami G, Moshang T et al. Prominent proptosis in childhood thyroid eye disease. Ophthalmology 1996 103 779-784.
25. Bahn RS & Heufelder AE. Pathogenesis of Graves' ophthalmopathy. New England Journal of Medicine 1993 329 1468-1475.
26. Gorman CA. Temporal relationship between onset of Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clinic Proceedings 1983 58 515-519.
27. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H et al. Severe congenital hyperthyroidism caused by a germ-line neomutation in the extracellular portion of the thyrotropin receptor. Journal of Clinical Endocrinology and Metabolism 1998 83 1431-1436.
28. Holzapfel HP, Wonerow P, von Petrykowski W, Henschen M, Scherbaum WA & Paschke R. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. Journal of Clinical Endocrinology and Metabolism 1997 82 3879-3884.
29. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, Joss E et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. New England Journal of Medicine 1995 332 150-154.
30. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL & Rodd C. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281- > isoleucine) in the extracellular domain of the thyrotropin receptor. Journal of Clinical Investigation 1997 100 1634-1639.
31. Lavard L, Sehested A, Brock Jacobsen B, Muller J, Perrild H, Feldt-Rasmussen U et al. Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr). Hormone Research 1999 51 43-46.
32. Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinology and Metabolism Clinics of North America 1989 27 225.
33. Cooper DS. Which anti-thyroid drug? American Journal of Medicine 1986 80 1165-1168.
34. Cooper DS. Antithyroid drugs. New England Journal of Medicine 1984 311 1353-1362.
35. Greer MA, Meihoff WC & Studer H. Treatment of hyperthyroidism with a single daily dose of propylthiouracil. New England Journal of Medicine 1965 272 888-891.
36. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. New England Journal of Medicine 1991 324 947-953.
37. McIver B, Rae P, Beckett G, Wilkinson E, Gold A & Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. New England Journal of Medicine 1996 334 220-224.
38. Tan SH, Lee BW, Wong HB & Uma R. Relapse markers in childhood thyrotoxicosis. Clinical Pediatrics 1987 26 136-139.
39. La Franchi S & Hanna CE. Graves' disease in the neonatal period and childhood. In Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text, 8th edn, pp 989-997. Eds LE Braverman & RD Utiger. New York: Lippincott, 2000.
40. Foley TP Jr, White C & New A. Juvenile Graves' disease: usefulness and limitations of thyrotropin receptor antibody determinations. Journal of Pediatrics 1987 110 378-386.
41. Rees Smith B, McLachlan SM & Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocrine Reviews 1988 9 106-121.
42. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB & Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997 7 755-760.
43. Williams KV, Nayak S, Becker D. Reyes J & Burmeister LA. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? Journal of Clinical Endocrinology and Metabolism 1997 82 1727-1733.
44. Hardee JT, Barnett AL, Thannoun A, Eghtesad B, Wheeler D & Jamal MM. Propylthiouracil-induced hepatotoxicity. Western Journal of Medicine 1996 165 144-147.
45. Limaye A & Ruffolo PR. Propylthiouracil-induced fatal hepatic necrosis. American Journal of Gastroenterology 1987 82 152-154.
46. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z & Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. Journal of Clinical Endocrinology and Metabolism 2000 85 3678-3682.
47. Andrassy RJ, Buckingham BA & Weitzman JJ. Thyroidectomy for hyperthyroidism in children. Journal of Pediatric Surgery 1980 15 501-504.
48. Hayles AB, Chaves-Carballo E & McConahey WM. The treatment of hyperthyroidism (Graves' disease) in children. Mayo Clinic Proceedings 1967 42 218-224.
49. Rivkees SA, Sklar C & Freemark M. Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment. Journal of Clinical Endocrinology and Metabolism 1998 83 3767-3776.
50. Foster RS Jr. Morbidity and mortality after thyroidectomy. Surgery, Gynecology and Obstetrics 1978 146 423-429.
51. Buckingham BA, Costin G, Roe TF, Weitzman JJ & Kogut MD. Hyperthyroidism in children. A reevaluation of treatment. American Journal of Diseases of Children 1981 135 112-117.
52. Ching T, Warden MJ & Fefferman RA. Thyroid surgery in children and teenagers. Archives of Otolaryngology 1977 103 544-546.
53. Miccoli P, Vitti P, Rago T, Iacconi F, Bartalena L, Bogazzi F et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 1996 120 1020-1024.
54. Perzik SL. Total thyroidectomy in Graves' disease in children. Journal of Pediatric Surgery 1976 11 191-194.
55. Thompson NW, Dunn EL, Freitas JE, Sisson JC, Coran AC & Nishiyama RH. Surgical treatment of thyrotoxicosis in children and adolescents. Journal of Pediatric Surgery 1977 12 1009-1018.
56. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 1995 141 259-277.
57. Schlumberger M & Pacini F. Thyroid tumors after external irradiation to the neck. In Thyroid Tumors, pp 243-255. Eds M Schlumberger & F Pacini. Paris: Nucleon, 2003.
58. Becker DV & Sawin CT. Radioiodine and thyroid disease: the beginning. Seminars in Nuclear Medicine 1996 26 155-164.
59. Chapman EM. History of the discovery and early use of radioactive iodine. Journal of the American Medical Association 1983 250 2042-2044.
60. Levy WJ, Schumacher OP & Gupta M. Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleveland Clinic Journal of Medicine 1988 55 373-382.
61. Sheline GE, Lindsay S, McCormack KR & Galante M. Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. Journal of Clinical Endocrinology and Metabolism 1962 22 8-17.
62. Hayek A, Chapman EM & Crawford JD. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. New England Journal of Medicine 1970 283 949-953.
63. 131I) for hyperthyroidism. New England Journal of Medicine 1975 292 167-171.
64. Snyder S. Vocal cord paralysis after radioiodine therapy. Journal of Nuclear Medicine 1978 19 975-976.
65. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D et al. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. Journal of Clinical Endocrinology and Metabolism 1998 83 40-46.
66. Murakami Y, Takamatsu J, Sakane S, Kuma K & Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. Journal of Clinical Endocrinology and Metabolism 1996 81 3257-3260.
67. Hancock LD, Tuttle RM, LeMar H, Bauman J & Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clinical Endocrinology 1997 47 425-430.
68. Yoshida K, Aizawa Y, Kaise N, Fukazawa H, Kiso Y, Sayama N et al. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey. Journal of Endocrinological Investigation 1996 19 682-686.
69. Rivkees SA & Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 2003 111 745-749.
70. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM & Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. Journal of Clinical Endocrinology and Metabolism 1974 38 976-998.
71. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. Journal of American Medical Association 1998 280 347-355.
72. Freitas JE, Swanson DP, Gross MD & Sisson JC. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? Journal of Nuclear Medicine 1979 20 847-850.
73. Hamburger JI. Management of hyperthyroidism in children and adolescents. Journal of Clinical Endocrinology and Metabolism 1985 60 1019-1024.
74. Zimmerman D & Lteif AN. Thyrotoxicosis in children. Endocrinology and Metabolism Clinics of North America 1998 27 109-126.
75. Clark JD, Gelfand MJ & Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. Journal of Nuclear Medicine 1995 36 442-445.
76. Starr P, Jaffe HL & Oettinger L Jr. Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 follow-up. Journal of Nuclear Medicine 1969 10 586-590.
77. Farbota LM, Calandra DB, Lawrence AM & Paloyan E. Thyroid carcinoma in Graves' disease. Surgery 1985 98 1148-1153.
78. Gorman CA & Robertson JS. Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma. Annals of Internal Medicine 1978 89 85-90.
79. Rivkees SA. The management of hyperthyroidism in children with emphasis on the use of radioactive iodine. Pediatric Endocrine Reviews 2004 1 (Suppl 1) 212-221.
80. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. New England Journal of Medicine 1992 326 1733-1738.
81. Bartlena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine 1998 338 73-78.
82. Gerber FR, Taylor FH, deLevie M, Drash AL & Kenny FM. Normal standards for exophthalmometry in children 10 to 14 years of age: relation to age, height, weight, and sexual maturation. Journal of Pediatrics 1972 81 327-329.
83. Chan W, Wong GW, Fan DS, Cheng AC, Lam DS & Ng JS. Ophthalmopathy in childhood Graves' disease. British Journal of Ophthalmology 2002 86 740-742.
84. Cheetham TD, Wraight P, Hughes IA & Barnes ND. Radioiodine treatment of Graves' disease in young people. Hormone Research 1998 49 258-262.
85. Krassas GE. Somatostatin analogues in the treatment of thyroid eye disease. Thyroid 1998 8 443-445.
86. Krassas GE, Dumas A, Pontikides N & Kaltsas T. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clinical Endocrinology 1995 42 571-580.
87. Krassas GE, Kaltsas T, Dumas A, Pontikides N & Tolis G. Lanreotide in the treatment of patients with thyroid eye disease. European Journal of Endocrinology 1997 136 416-422.
88. Krassas GE & Kahaly GJ. The role of octreoscan in thyroid eye disease. European Journal of Endocrinology 1999 140 373-375.
89. Pasquali D. Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves' disease. Journal of Clinical Endocrinology and Metabolism 2002 87 5125-5129.
90. Pasquali D, Vassallo P, Esposito D, Bonavolonta G, Bellastella A & Sinisi AA. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. Journal of Molecular Endocrinology 2000 25 63-71.
91. Krassas GE. Thyroid eye disease in children and adolescents - new therapeutic approaches. Journal of Pediatric Endocrinology and Metabolism 2001 14 97-100.
92. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. European Journal of Endocrinology 1994 131 467-473.
93. Maenpaa J & Kuusi A. Childhood hyperthyroidism. Results of treatment. Acta Paediatrica Scandinavica 1980 69 137-142.
94. Buckingham BA, Costin G, Roe TF, Weitzman JJ & Kogut MD. Hyperthyroidism in children. A reevaluation of treatment. American Journal of Diseases of Children 1981 135 112-117.
95. Lippe BM, Landaw EM & Kaplan SA. Hyperthyroidism in children treated with long-term medical therapy: twenty-five percent remission every two years. Journal of Clinical Endocrinology and Metabolism 1987 64 1241-1245.
96. Gorton C, Sadeghi-Nejad A & Senior B. Remission in children with hyperthyroidism treated with propylthiouracil. Long-term results. American Journal of Diseases of Children 1987 141 1084-1086.
97. Shiroozu A, Okamura K, Ikenoue H, Sato K, Nakashima T, Yoshinari M et al. Treatment of hyperthyroidism with a small single daily dose of methimazole. Journal of Clinical Endocrinology and Metabolism 1986 63 125-128.